Vitamin D supplementation for severe pneumonia — A randomized controlled trial
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
To determine the role of oral vitamin D supplementation for resolution of severe pneumonia in under-five children.
Randomized, double blind, placebo-controlled trial.
Inpatients from a tertiary care hospital.
Two hundred children [mean (SD) age: 13.9 (11.7) months; boys: 120] between 2 months to 5 years with severe pneumonia. Pneumonia was diagnosed in the presence of fever, cough, tachypnea (as per WHO cut-offs) and crepitations. Children with pneumonia and chest indrawing or at least one of the danger sign (inability to feed, lethargy, cyanosis) were diagnosed as having severe pneumonia. The two groups were comparable for baseline characteristics including age, anthropometry, socio-demographic profile, and clinical and laboratory parameters.
Oral vitamin D (1000 IU for <1 year and 2000 IU for >1 year) (n=100) or placebo (lactose) (n=100) once a day for 5 days, from enrolment. Both the groups received antibiotics as per the Indian Academy of Pediatrics guidelines, and supportive care (oxygen, intravenous fluids and monitoring).
Primary: time to resolution of severe pneumonia. Secondary: duration of hospitalization and time to resolution of tachypnea, chest retractions and inability to feed.
Median duration (SE, 95% CI) of resolution of severe pneumonia was similar in the two groups [vitamin D: 72 (3.7, 64.7–79.3) hours; placebo: 64 (4.5, 55.2–72.8) hours]. Duration of hospitalization and time to resolution of tachypnea, chest retractions, and inability to feed were also comparable between the two groups.
Short-term supplementation with oral vitamin D (1000–2000 IU per day for 5 days) has no beneficial effect on resolution of severe pneumonia in under-five children. Further studies need to be conducted with higher dose of Vitamin D or longer duration of supplementation to corroborate these findings.
- UNICEF/ WHO. Pneumonia: The Forgotten Killer of Children. Geneva: WHO; 2006.
- Zinc Investigators’ Collaborative Group. Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials. J Pediatr. 1999;135:687–697.
- Brooks WA, Yunus M, Santoshan M, Wahed MA, Nahar K, Yeasmin S, et al. Zinc for severe pneumonia in very young children; double-blinded placebo-controlled trial. Lancet. 2004;363:1683–1688. CrossRef
- Aggarwal R, Sentz J, Miller MA. Zinc administration in prevention of childhood diarrhea and respiratory illness: A meta-analysis. Pediatrics. 2007;6:1120–1130. CrossRef
- Vitamin A and Pneumonia Working Group. Potential interventions for the prevention of childhood pneumonia in developing countries: a meta-analysis of data from field trials to assess the impact of vitamin A supplementation on pneumonia morbidity and mortality. Bull WHO. 1995;73:609–619.
- Rallof J. The antibiotic vitamin. Deficiency in vitamin D may predispose people to infection. Science. 2006;170;312. CrossRef
- Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311:1770–1773. CrossRef
- Lemire JM, Adams JS, Kermani-Arab V, Bakke AC, Sakai R, Jordan SC. 1, 25-dihydroxyvitamin D3 suppresses human T helper inducer lymphocyte activity in vitro. J Immunol. 1985;134:3032–3035.
- Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, et al. Cutting edge: 1, 25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004;173:2909–2912.
- Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly upregulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB. 2005;19: 1067–1077. CrossRef
- Wayse V, Yousafzai A, Mogale K, Filteau S. Association of subclinical vitamin D deficiency with severe acute lower respiratory infection in Indian children under 5 years. Eur J Clin Nutr. 2004;58:563–567. CrossRef
- Auss-Kettis A, Bjornesjo KB, Manneimer E, Cvibach T, Clark P, Mammo D. The occurrence and clinical picture of disease in a clinic in Addis Ababa. Ethiopia Med J. 1965;3:109–121.
- Manaseki-Holland S, Masher I, Bruce J, Mughal Z, Chandramohan D, Walraven G. Effects of vitamin D supplementation to children diagnosed with pneumonia in Kabul: a randomized controlled trial. Trop Med Int Health. 2010;15:1148–1155. CrossRef
- WHO Child and Adolescent Health and Development (CAH). Integrated management of neonatal and childhood illness and HIV. Physician Chart Booklet. Ministry of Health & Family Welfare, Govt. of India, 2007.
- Physical status: The Use and Interpretation of Anthropometry. Report of a WHO Expert Committee. Geneva: WHO; WHO Technical Report Series No. 854. 1995.
- Agarwal R, Singh V, Yewale V. RTI Facts. IAP Consensus Guidelines on Rational Management of Respiratory Tract Infections in Children. Mumbai: Indian Academy of Pediatrics; 2006.
- Office of Dietary Supplements: NIH Clinical Center. Dietary Supplement Fact Sheet: Vitamin D. Bethesda: National Institutes of Health; 2007.
- Saadi HF, Dawodu A, Afandi B, Zayed R, Benefict S, Nagelkerke N, et al. Effect of combined maternal and infant vitamin D supplementation on vitamin D status of exclusively breastfed infants. Matern Child Nutr. 2009;5:525–532.
- Veith R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Nutr. 1999;69:842–856.
- Vitamin D supplementation for severe pneumonia — A randomized controlled trial
Volume 49, Issue 6 , pp 449-454
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Vitamin D